Definitive Contract HHSD200201033943C

This is a federal contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Pfizer Inc.'s Wyeth division. The contract, valued at $15,297,409,927.00, is for the Vaccines for Children (VFC) Pediatric Vaccine Contract and has a period of performance ending on March 31, 2010. The contract is a Definitive Contract with a Firm Fixed Price pricing type and does not have a set-aside designation. The contract is for the delivery of pediatric vaccines...

This is a definitive, firm fixed-price contract awarded by the CDC Office of Acquisition Services, a civilian agency, to Glaxosmithkline Holdings (Americas) Inc. on April 1, 2009. The contract, valued at $13,015,897,209.20, is for the provision of pediatric vaccines under the Vaccines for Children (VFC) program. The contract has a period of performance through March 31, 2010 and does not have a set-aside designation. As the prime contractor, Glaxosmithkline Holdings (Americas) Inc. will be...

This is a $41,402,500.00 firm fixed price definitive contract awarded to Pfizer Inc. (Pfizer) by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) for the provision of adult vaccines. The contract has a performance period ending on June 30, 2018, with no set-aside designation mentioned. As the prime contractor, Pfizer will be directly delivering the vaccines without the involvement of major subcontractors. The vaccines to be supplied include those for...

This is a firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. for the supply of adult vaccines. The contract has a ceiling value of $54,499,343.31 and an ultimate completion date of June 30, 2016. The contract does not have a set-aside designation. Pfizer, the prime contractor, is a global pharmaceutical corporation that plays a significant role in supplying medical products and services to the U.S. federal government. This contract...

This is a definitive, firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Novartis Vaccines and Diagnostics, Inc., a foreign-owned for-profit organization. The contract, valued at $3,998,636,358.75, is for the TAS 00HCVGBC-2010-82345 - Novartis Pediatric Vaccine Contract and does not have a set-aside designation. The contract has an ultimate completion date of March 31, 2011. As a pediatric vaccine contract, this award...

This is a $6,859,517,906.00 firm fixed-price definitive contract awarded by the Bureau for Global Health, a civilian agency within the U.S. government, to Pfizer Inc. for the provision of COVID-19 vaccines for international donation. The contract has an ultimate completion date of February 29, 2024 and does not utilize any set-aside designations. Pfizer is the prime contractor for this award, which is associated with the company's existing Vaccines for Children (VFC) program contract with the...

This $2,299,932.44 firm-fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. for the storage and rotation of Pfizer's COVID-19 vaccine. The contract has an ultimate completion date of July 31, 2022 and was awarded on August 1, 2017. The contract does not have a set-aside designation. Pfizer, a large global pharmaceutical corporation, is the prime contractor for this award. The contract is part of a larger Indefinite Delivery Vehicle (IDV) that...

This is a Firm Fixed Price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a large pharmaceutical manufacturer. The $2,201,243.29 contract is for the storage and rotation of Pfizer vaccines. The contract has an ultimate completion date of July 31, 2027. This contract is not set aside for small businesses. Pfizer is the prime contractor, and there are no major subcontractors mentioned. The contract is part of the CDC's broader efforts to...

This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of pharmaceutical goods. The $28.3 billion firm fixed price contract is for the provision of pediatric vaccines under the Vaccines for Children (VFC) program. The contract has no set-aside designation and runs through March 31, 2010. Sanofi Pasteur operates a facility in Swiftwater, Pennsylvania to fulfill the...

This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of pharmaceutical goods. The $540,787,384.50 firm fixed price contract is for the provision of 2017 pediatric flu vaccines, with a performance period ending on February 28, 2018. This award is not associated with a set-aside designation. Sanofi Pasteur Inc. is a major supplier of vaccines and pharmaceuticals to various U.S. government...